North America Pharmaceutical Isolator Market Size and Competitive Analysis by 2028
North America Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)
- Status : Published
- Report Code : TIPRE00025888
- Category : Life Sciences
- No. of Pages : 137
- Available Report Formats :
- Last update date : November 14, 2021
2021 Market Size
US$ 2,532.56 Mn
Base year value
2028 Forecast
US$ 4,409.02 Mn
Projected by 2028
CAGR 2022-2028
8.2 %
Growth rate
Addressable Market
US$ 24,600.73 Mn
(2022-2028)
The North America pharmaceutical isolator market is expected to grow from US$ 2,532.56 million in 2021 to US$ 4,409.02 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.
The US, Canada, and Mexico are economies in North America. Growing investments by pharmaceutical and biotechnology industry is expected to surge the market growth. Several big and small pharmaceutical companies are engaged in the development and manufacturing of new and novel molecules for life-threatening conditions. Pharmaceutical isolator systems have been regarded as a key technology in the drug discovery process. Thus, the adoption of pharmaceutical isolators is increasing to ensure contamination-free manufacturing and product handling. The pharmaceutical isolator provides safety to an operator from the exposure of harmful drugs, eliminates the possibilities of cross-contamination, and maintains the standard of drug quality. In the pharmaceutical industry, it is extremely important to maintain immense caution during the product manufacturing process. Different types of isolators are available in the pharmaceutical market that provide an optimum level of sterility in the product manufacturing process. The handling of pharmaceuticals with high potency ingredients, such as hormones and antibiotics. Biologic drugs need a greater level of precautions. Increased investments by pharmaceutical and biotechnology companies and extensive drug pipelines for the treatment of various chronic diseases, such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders, are the prominent drivers for the growth of the North America pharmaceutical isolator market.
In case of COVID-19, North America is highly affected specially the US. the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their research and development for innovating vaccine against the coronavirus. In May 2020, The U.S. Department of Health and Human Services had collaborated with private players to expand pharmaceutical products in the United States against COVID-19 and further medical emergencies. Phlow Corporation of Richmond, Virginia, leads the collaboration. It has the capacity to produce active pharmaceutical ingredients (APIs) and chemical compounds for critical medicines. It is expected that the production of pharmaceutical products will assist in preventing drug shortages, especially during the COVID-19 pandemic. The collaboration aims to provide the health care systems with complete, sterile, and injectable generic medicines at risk of shortage. The agreement between the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at HHS, is done for four years with US$ 354 million. Thus, the collaboration is expected to show a positive impact on the pharmaceutical isolator market in the coming few years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America pharmaceutical isolator market. The North America pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Pharmaceutical Isolator Market Segmentation
North America Pharmaceutical Isolator Market – By Type
- Open Isolators
- Closed Isolators
North America Pharmaceutical Isolator Market – By Pressure
- Positive Pressure
- Negative Pressure
North America Pharmaceutical Isolator Market – By Configuration
- Floor Standing
- Modular
- Compact
- Mobile
North America Pharmaceutical Isolator Market – By Application
- Aseptic
- Sampling & Weighing
- Fluid Dispensing
- Containment
- Others
North America Pharmaceutical Isolator Market – By End User
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research and Academic Laboratories
- Other
North America Pharmaceutical Isolator Market, by Country
- US
- Canada
- Mexico
North America Pharmaceutical Isolator Market -Companies Mentioned
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
- Schematic Engineering Industries
North America Pharmaceutical Isolator Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,532.56 Million |
| Market Size by 2028 | US$ 4,409.02 Million |
| CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners provided valuable market intelligence that supported our global go-to-market strategy. Their team was professional, responsive, and attentive to our feedback, providing thoughtful analysis and helpful methodological clarifications throughout the project.
Junmo Kim Chief Financial Officer (CFO), Enertech Co., Ltd.
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for